The essence of leukemia stem cells

Area of Science:

• Hematology
• Cancer Biology
• Stem Cell Research

Background:

• The leukemia stem cell (LSC) model posits that rare, stem cell marker-expressing cells drive leukemia initiation, recurrence, and drug resistance.
• LSCs have been considered prime therapeutic targets due to their role in disease progression and treatment failure.
• Recent findings challenge fundamental aspects of the LSC model, including phenotype variability and the driving role of rare primitive cells.

Purpose of the Study:

• To critically evaluate the current understanding of the leukemia stem cell (LSC) model.
• To discuss recent challenges and evolving concepts regarding LSC heterogeneity and function.
• To summarize existing evidence supporting and questioning the LSC model's explanatory power for leukemia biology.

Main Methods:

• Review of existing literature on leukemia stem cells.
• Analysis of data from xenograft assays and mouse leukemia models.
• Integration of recent findings on genetic variations and tumor heterogeneity.

Main Results:

• LSC phenotypes exhibit significant inter-patient variability.
• Technical factors, such as immunodeficient mouse strains, influence xenograft assay outcomes.
• Not all leukemias are driven by rare, primitive LSCs; some involve larger populations of more mature LSCs.
• Genetic variations contribute to leukemia heterogeneity, potentially independent of the LSC model.
• Despite challenges, evidence persists for primitive LSCs correlating with therapeutic resistance and poor prognosis.

Conclusions:

• The traditional LSC model requires refinement to account for observed heterogeneity and variability.
• Further research is needed to reconcile conflicting data and understand the precise role of LSCs in different leukemia subtypes.
• Developing targeted therapies requires a nuanced understanding of LSC biology, acknowledging both primitive and more mature LSC populations.